Abionyx Pharma SA (ABNX) — Financial Flexibility Index
Abionyx Pharma SA (ABNX) has a Financial Flexibility Index of -0.20x as of June 2025. Free cash flow of €-1.54 Million (operating CF €-1.70 Million minus capex €162.00K) represents 0% of total liabilities (€7.56 Million). Check ABNX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Abionyx Pharma SA Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Abionyx Pharma SA across 12 annual periods. For the full cash flow conversion analysis, see ABNX cash flow metrics.
Annual Financial Flexibility Index for Abionyx Pharma SA (2013–2024)
Year-by-year free cash flow to debt coverage for Abionyx Pharma SA. Explore Abionyx Pharma SA (ABNX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.58x | €-3.52 Million | €-3.60 Million | €6.03 Million | ▼ -13.3% |
| 2023 | -0.52x | €-3.57 Million | €-3.70 Million | €6.91 Million | ▼ -40.3% |
| 2022 | -0.37x | €-3.18 Million | €-3.36 Million | €8.65 Million | ▲ +37.1% |
| 2021 | -0.59x | €-6.53 Million | €-6.69 Million | €11.15 Million | ▼ -374.6% |
| 2020 | -0.12x | €-451.00K | €-599.00K | €3.66 Million | ▲ +88.5% |
| 2019 | -1.07x | €-3.85 Million | €-3.95 Million | €3.58 Million | ▼ -67.0% |
| 2018 | -0.64x | €-5.98 Million | €-6.00 Million | €9.30 Million | ▲ +31.9% |
| 2017 | -0.94x | €-8.88 Million | €-9.09 Million | €9.41 Million | ▲ +28.9% |
| 2016 | -1.33x | €-19.19 Million | €-19.20 Million | €14.46 Million | ▼ -26.6% |
| 2015 | -1.05x | €-13.54 Million | €-13.71 Million | €12.91 Million | ▼ -244.1% |
| 2014 | -0.30x | €-3.30 Million | €-3.30 Million | €10.82 Million | ▲ +83.7% |
| 2013 | -1.87x | €-14.48 Million | €-14.49 Million | €7.76 Million | — |